MFN2与BAG6协同调控ROS和自噬流保护脑再灌注损伤
该研究在C57BL/6小鼠大脑中动脉闭塞模型和SY5Y细胞氧糖剥夺/复氧模型中,通过敲低和过表达MFN2与BAG6,发现神经元特异性MFN2缺失加重脑缺血/再灌注损伤,而过表达MFN2或BAG6可减轻损伤;两者共过表达通过降低脑内ROS水平、稳定线粒体功能和调控自噬协同保护。MFN2-BAG6轴是卒中治疗的潜在靶点。
要点
- 神经元MFN2缺失加重脑缺血/再灌注损伤,过表达MFN2减轻损伤。
- MFN2与BAG6直接相互作用,BAG6过表达模拟MFN2过表达的保护效应。
- MFN2与BAG6共过表达协同降低脑ROS、稳定线粒体功能并调控自噬。
核心结论
- MFN2通过降低ROS水平和经与BAG6相互作用调控自噬两条途径改善卒中结局。
- BAG6增强MFN2的降ROS和细胞保护作用,MFN2-BAG6轴是卒中治疗的潜在靶点。
研究设计与样本
- 研究在雌雄C57BL/6小鼠(10-12周)大脑中动脉闭塞模型和SY5Y细胞氧糖剥夺/复氧模型中开展。
- 采用神经元特异性条件性敲除或siRNA介导的敲低以及腺相关病毒载体或质粒载体过表达MFN2。
- 采用48分神经功能评分和转棒试验评估神经功能缺损,TTC染色评估梗死体积。
- 采用RealTime凋亡与坏死检测试剂盒测量凋亡和坏死性细胞死亡,功能实验分析ROS形成和自噬流。
- 采用Western blot、免疫亲和色谱、质谱和免疫沉淀分析评估蛋白表达与相互作用。
主要发现
- 神经元特异性MFN2缺失加重脑缺血/再灌注损伤,而MFN2过表达减轻损伤。
- MFN2缺陷升高线粒体ROS水平并抑制自噬,MFN2过表达降低ROS水平。
- 免疫沉淀研究显示MFN2与BAG6存在直接相互作用。
- BAG6过表达模拟MFN2过表达对脑缺血/再灌注损伤的效应。
- MFN2与BAG6共过表达通过大幅降低脑ROS水平、稳定线粒体功能和调控自噬协同减轻缺血/再灌注损伤。
临床怎么用
- MFN2-BAG6轴可作为卒中治疗的潜在靶点,但尚需临床研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: MFN2 (mitofusin-2), a transmembrane dynamin-like protein located on the outer mitochondrial membrane, plays a key role in regulating mitochondrial fusion and autophagy. In vitro studies suggested that MFN2 may exert neuroprotective effects postischemia. In gain-of-function and loss-of-function experiments, we investigated MFN2'·s roles in regulating neuronal ischemia/reperfusion injury in vivo and in vitro. METHODS: MFN2 was knocked down by neuron-specific conditional knockout or siRNA-mediated knockdown and overexpressed by adeno-associated viral vectors or plasmid vectors in C57BL/6 mice of both sexes (10-12 weeks) exposed to middle cerebral artery occlusion and SY5Y cells exposed to oxygen-glucose deprivation/reoxygenation. Neurological deficits were examined using a 48-point score and rotarod tests. Infarct volume was assessed by 2,3,5-triphenyltetrazolium chloride staining. A RealTime Apoptosis and Necrosis Assay was used to measure apoptotic and necrotic cell death. Reactive oxygen species (ROS) formation and autophagic flux were analyzed by functional assays. Protein expression and interaction were evaluated using Western blots, immunoaffinity chromatography, mass spectrometry, and immunoprecipitation analysis. To assess the role of MFN2's interaction partner BAG6, BAG6 was overexpressed in middle cerebral artery occlusion mice and overexpressed or knocked down in SY5Y cells. RESULTS: Neuron-specific MFN2 deletion exacerbated cerebral ischemia/reperfusion injury, while MFN2 overexpression reduced it. MFN2 deficiency elevated mitochondrial ROS levels and inhibited autophagy, whereas MFN2 overexpression decreased ROS levels. In immunoprecipitation studies, we found a direct interaction between MFN2 and BAG6. Of note, BAG6 overexpression mimicked the effect of MFN2 overexpression on cerebral ischemia/reperfusion injury. Combined MFN2 and BAG6 overexpression synergistically reduced ischemia/reperfusion injury by drastically decreasing cerebral ROS levels, stabilizing mitochondrial function, and modulating autophagy. CONCLUSIONS: Our study suggests that MFN2 enhances stroke outcome through 2 pathways: by decreasing ROS levels and modulating autophagy via interaction with BAG6. BAG6 potentiates the ROS-lowering, cytoprotective MFN2 actions. The MFN2-BAG6 axis represents a promising target for stroke therapy.
引用
- Lu D, Yang Y, Huang G, et al. MFN2 and BAG6 Synergistically Protect Against Cerebral Reperfusion Injury by Regulating ROS Levels and Autophagic Flux. Stroke. 2025. PMID: 40891328. doi:10.1161/STROKEAHA.125.052689
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。